Skip to content
Sign in
Artwork for Charged Alpha Stock Encyclopedia
BusinessInvesting

Charged Alpha Stock Encyclopedia

Colton Thomas

⚡ Charged Alpha — The S&P 500 Stock Encyclopedia Data-driven deep dives into every stock in the S&P 500 after every earnings report. Each episode breaks down one company from open to close: what they do, how the numbers look, what Wall Street thinks, the bull case, the bear case. 🛠️ Check out our free beginner-friendly screening tools for stocks, ETFs, options, crypto, bonds, REITs & more at https://chargedalpha.com — no signup, no paywall. 📊 What you get in every episode: Company overview & competitive moat Full financial breakdown — valuation, revenue, margins, cash flow Analyst consensus & price targets Bull case vs. bear case Peer comparison, options flow & insider activity Key metrics to watch ⚠️ Not financial advice. For educational purposes only. Episodes are researched, written, and produced using AI-assisted tools. All data aggregated from publicly available sources. #stocks #investing #S&P500 #stockanalysis #chargedalpha #financialdata #earningsreport #earnings

Play
Open in
  • 96 episodes
  • Avg 14 min
  • English

Episodes 96

NewestOldestLongest
All20Unplayed20In progress0Played0
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • Yesterday · 15 min

    Gorilla Technology (GRRR): Revenue Doubled And The Gross Line Went Negative

    Gorilla Technology (GRRR) H1 2026 — H1 2026 (six months to 30 June): revenue $78.4M, up 99.3%; gross profit $3.8M, down 71.4%; gross margin 4.9% from 34.2%. IFRS operating loss $47.2M, net loss $46.9M, loss per share $1.74; adjusted EPS -$0.58. The June quarter, derived by subtracting the filed Q1 from the filed half: revenue $50.1M (+138% YoY, +78% QoQ) and gross profit of MINUS $2.11M. Adjusted EPS -$0.40 against a +$0.03 bar. FY2026 guidance raised to at least $200M. The stock fell 11.31% to $14.04 on 25 August and closed the week at $14.41. Gorilla's June quarter was the largest it has ever printed and the first in which it sold goods for less than they cost: gross profit of minus $2.11M on $50.1M of revenue. Every dollar of the growth is a hardware line that did not exist a year ago ($52.5M, against $0 external in H1 2025), while the service business that carried all of the historic margin shrank 34.2%. THE CALL: BEARISH (3/5, THE BIGGEST QUARTER EVER, SOLD BELOW COST) — base-case value ~$12.7 vs ~$14.41 today. KEY METRICS: - CALL: BEARISH 3/5, fair value $12.70 vs the $14.41 close of 28 August (-11.8%). Bear $5.94, base $13.39, bull $26.74, weighted 45/35/20. Street: Buy, $40.50 average (Compass Point $44, Cantor $40, Northland $40, A.G.P. $38) - and every one of those targets predates the release. - THE GROSS LINE: H1 gross profit $13.4M to $3.8M (-71.4%) while revenue doubled. June-quarter gross profit MINUS $2.11M against $7.04M a year earlier. Incremental gross margin on everything added year on year: -24.6% (revenue +$39.0M, cost of sales +$48.6M). - THE MIX: hardware $52.5M from $0 external (H1 2025's $22.9M was 100% eliminated on consolidation); services $25.9M from $39.3M, -34.2%. All hardware is booked at a point in time, all services over time. - THE FUNDING: $232M of 7.50% convertible notes in 63 days ($107M June, $125M July). Of the June $107M only $62.7M is debt - the other $44.3M is the conversion option. Filed effective interest rate 21.59%. Conversion at $25.4826 would add 9.10M shares to 27.24M, +33.4%. - THE RECEIVABLES: receivables plus contract assets $145.3M against $78.4M of half-year revenue (336 days), of which $104.8M is unbilled. 51.2% of invoiced receivables are past due; the credit-loss provision went $0.94M to $5.16M. Unfulfilled contracts -28.2% to $72.7M. What to watch: UP: a September quarter inside the guided $48-50M with gross margin back into double digits; cash actually collected against the $104.8M of unbilled contract assets. DOWN: another quarter of revenue growth on a negative gross margin; the credit-loss provision compounding past $5.2M; contract assets rising again at December. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Yesterday · 13 min

    Materialise (MTLS): One Segment Earns 118% Of The Profit

    Materialise (MTLS) Q2 2026 — Q2 2026 (three months to 30 June, filed in EUR): revenue EUR70.1M, +8.1% YoY; adjusted EBIT EUR3.9M, +26.9%; net profit EUR3.3M, EUR0.06 per ordinary share and per ADS. But the REPORTED operating result was EUR2.8M against EUR2.7M - essentially unchanged. Full-year adjusted EBIT guidance RAISED to EUR12-14M; revenue guidance reaffirmed at EUR273-283M. The 6-K landed pre-market on 27 Aug: +11.24% on 8.2x median volume, then 53% handed back the next session to close at $7.02. One of Materialise's three businesses earned more money last half than the entire company did. Materialise Medical produced EUR20.8M of segment adjusted EBITDA in the six months to 30 June; the whole company kept EUR17.6M - 118%, on 51% of group revenue. It is not a quarter: the same ratio was 133% across 2025 and 113% across 2024. Software, the highest-quality revenue in the group, is the only segment shrinking. Manufacturing is a third of revenue and lost EUR6.2M at the segment operating line. THE CALL: HOLD (3/5, ONE SEGMENT IS THE COMPANY, AND NOTHING FORCES ANYONE TO SEPARATE IT) — base-case value ~$7.21 vs ~$7.02 today. KEY METRICS: - CALL: HOLD 3/5, fair value $7.21 vs the $7.02 close of 28 August (+2.7%). Bear $6.01 (discounted cash flow), base $7.40 (group at 8.5x guided adjusted EBITDA), bull $8.44 (sum of the parts), weighted 40/25/35. One dated Street target: Cantor Fitzgerald, Overweight, $10.00, 20 February 2026, set with the ADS at $5.48. - THE SPINE - segment adjusted EBIT, June half: Medical +EUR17.4M, Software +EUR0.8M, Manufacturing -EUR6.2M, unallocated corporate -EUR5.6M. Those four sum to the EUR6.4M of consolidated adjusted EBIT Materialise reported. - THREE YEARS, NOT ONE QUARTER: Medical was 133% of group adjusted EBITDA across 2025 and 113% across 2024. Two-year segment revenue: Medical EUR116.4M to EUR134.2M, Manufacturing EUR106.5M to EUR92.5M, Software EUR43.9M to EUR40.9M. Group revenue barely moved. - BALANCE SHEET AND CAPEX: EUR74.2M of NET CASH, a fifth of the $407.1M market value. But depreciation was EUR11.3M in the half against EUR3.4M of capital spending - 0.31x. - VENDOR ERRORS NAMED ON-SLIDE: FMP's FY2025 revenue is 3.9% BELOW the filed figure; its earnings feed carries a PHANTOM 23 July 2026 print; its market cap is 1.0% high. ONE ADS IS ONE ORDINARY SHARE, proved from note 6.2. What to watch: UP: the medical share of group adjusted EBITDA falling below 100%; two consecutive periods of software revenue GROWTH; any announced separation or disposal of a segment. DOWN: capital spending staying below depreciation; manufacturing losses widening again; the full-year revenue guide being cut in November. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Yesterday · 13 min

    JinkoSolar (JKS): The $212M Operating Loss That Was Reported As $103M

    JinkoSolar (JKS) Q2 2026 — Q2 2026 (three months to 30 June): revenue RMB12.36BN / $1,821.2M, -31.3% YoY on module shipments of 15,961MW, -34.4%; gross margin 4.2% from 8.3% in Q1; operating expenses $287.3M against $75.6M of gross profit, so a $211.7M loss from operations. Net loss attributable to ordinary shareholders $102.8M, or $1.94 per ADS - but the company's own ADJUSTED loss is $134.2M, 31% BIGGER. Full-year shipment guidance cut from 75-85GW to 60-70GW. The 6-K landed pre-market on 26 Aug: the ADSs closed -11.87% and made a fresh 12-month closing low the next session. Making and selling solar modules lost JinkoSolar $211.7M in the June quarter. The loss reported to the owners of the ADSs was $102.8M - less than half of it. Both figures are correct and both are printed on the same filed statement of operations. The $108.9M in between is five non-operating items: government grants of $29.7M, the gain on selling 75.1% of the US business ($34.9M), a fair-value mark on a portfolio of private investments ($54.6M), an income tax benefit ($24.1M), and $84.0M of the group loss carried by the MINORITY holders of the majority-owned operating subsidiary. Not one of them is a solar module, and on the same morning the company cut its full-year shipment guidance by 15GW and made its head of strategic investment the chief executive. THE CALL: SELL (3/5, A LEVERED CYCLICAL WHOSE REPORTED LOSS IS HALF THE OPERATING ONE) — base-case value ~$9.90 vs ~$13.54 today. KEY METRICS: - CALL: SELL 3/5, fair value $9.90 vs the $13.54 close of 28 August (-26.9%). Bear $4.94, base $8.89, bull $20.86, weighted 35/45/20. Below both live Street targets: Goldman Sachs cut to $11.00 and Roth Capital to $16.00, both on 27 August. Their average of $13.50 is 4 cents UNDER the last close. - THE BRIDGE: loss from operations $211.7M; net loss attributable to ordinary shareholders $102.8M; ratio 2.06x, against 1.27x in the March quarter. The five items in between total $227.3M of help against $118.4M of drags - net interest $40.3M, an exchange loss on foreign-currency debt of $48.0M, and smaller items. - THE UNIT ECONOMICS: 0.47 cents of gross profit per watt shipped against 1.80 cents of operating cost per watt - 3.8x. A quarter earlier the gross line was 1.10 cents. Gross margin must reach ~15.8% to cover the overhead; it is 4.2%, an 11.6-point gap that WIDENED from 7.7 points a year ago. - THE BALANCE SHEET: $6,617M of total interest-bearing debt less $2,497M of cash = $4,121M of net debt, 5.8x the $716M market value. Cash fell $865M in the quarter (from $3,362M at 31 March) while a $1.50/ADS dividend (~$79M) was declared. Equity attributable to JinkoSolar is $2,152M - 12.3% of $17.5BN of assets. Book value $40.72 an ADS; the tape pays 0.33x book. - TWO VENDOR ERRORS NAMED ON-SLIDE: (1) FMP's epsActual of -2.53 is the company's ADJUSTED loss per ADS, not the filed GAAP -1.94. (2) FMP's market cap of $177.3M is 75% TOO LOW - it carries 13.09M shares where the release prints 211,435,343 weighted ordinary shares, and ONE ADS REPRESENTS FOUR ORDINARY SHARES. The correction makes the stock DEARER, not cheaper. What to watch: DOWN (our case): gross profit per watt staying under 1.80 cents; a second cut to the 60-70GW guide in November; net debt holding above $4BN against a sub-$1BN equity. UP (what would change our mind): two consecutive quarters of gross profit per watt above 1.80 cents; the January 2027 efficiency standard lifting realised prices on 40GW of TOPCon 3.0 capacity; net debt falling toward the equity value. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Yesterday · 13 min

    Gaotu Techedu (GOTU): More Cash Than Market Cap - And Two Thirds Of It Is Prepaid Tuition

    Gaotu Techedu (GOTU) Q2 2026 — Q2 2026 (three months to 30 June): net revenues RMB1,670.1M / $246.1M, +20.2% YoY, accelerating from +13.2% in Q1; gross margin 66.5%; operating expenses $185.8M against $163.7M of gross profit, so a $22.1M operating loss, narrowed from $35.6M. Net loss $20.0M, RMB0.57 (-$0.09) per ADS. Operating cash inflow $126.9M, +46.3% - but the six-month figure is $4.8M, -70.6%. The 6-K landed pre-market on 27 Aug: the ADSs gapped +6.9%, faded to $1.74, closed +5.20%, and added +3.30% the next session. Gaotu holds $588.5M of cash, restricted cash and investments against a market value of $441.9M. On a screen that is a negative enterprise value. But $384.9M of that cash is deferred revenue - tuition already collected for lessons that have not been taught - and the filed shareholders' equity of $154.2M has already netted it off for you. Fund the cost of teaching every lesson already sold, at the filed 33.5% cost ratio, and $380.7M survives: $1.62 an ADS, 86% of the share price. That leaves the market paying about $61.2M for a business turning over $1.06BN at a 66.5% gross margin, still growing 20%. THE CALL: SPEC BUY (3/5, A CASH FLOOR UNDER A BUSINESS THAT STILL LOSES MONEY) — base-case value ~$2.35 vs ~$1.88 today. KEY METRICS: - CALL: SPEC BUY 3/5, fair value $2.35 vs the $1.88 close of 28 August (+25.1%). Bear $0.96, base $2.34, bull $4.04, weighted 30/45/25. Street: 10 ratings, consensus Hold, and NO live target - the newest dated note from a named firm is Citigroup's $5.81 of 5 August 2024, 754 days stale. - THE FLOOR: net cash $509.6M ($588.5M less $78.9M of borrowings) against a $441.9M market value. Deducting the whole $384.9M deferred revenue balance leaves $124.7M ($0.53 an ADS); deducting only the 33.5% cost of delivering it leaves $380.7M ($1.62 an ADS, 86% of the price). Filed shareholders' equity is $154.2M. - THE SPINE: operating cash inflow was $126.9M (+46.3%) while deferred revenue rose $120.6M over the same three months - 95% of it. The March quarter was a $122.1M OUTFLOW while deferred revenue fell $114.0M - 93% of it. Both quarters together: $4.8M against $16.4M, -70.6%. Six months of it moved the cash pile $3.0M. - THE ADS RATIO: three ADSs represent two ordinary shares. 156,703,879 ordinary shares outstanding is 235.1M ADSs, so the market value is $441.9M - not the $682.0M published, which uses 362.7M ADSs and is 54% too high. Corroborated independently by the FY2025 20-F depositary disclosure. - THE QUARTER: revenue $246.1M (+20.2%), gross margin 66.5%, operating loss $22.1M vs $35.6M. Operating costs fell to 75.5% of revenue from 83.4% - a 7.9 point move that halved the gap to operating break-even, from 17.4 points to 9.0. Selling costs alone were $134.6M, 82.2% of gross profit. - WHERE WE DISAGREE: guided Q3 revenue, this quarter's gross margin and costs grown at the +8.8% they actually grew give a FY2026 operating LOSS of $46.7M. The vendor consensus has a $5.3M operating PROFIT, on four revenue analysts and one earnings analyst. We agree on revenue to within 0.6%. Our model crosses into profit in 2028. What to watch: UP: March-quarter gross billings above last March's $146.8M; the operating cost ratio falling below 66.5% of revenue; deferred revenue continuing to grow year on year. DOWN: two consecutive quarters of deferred revenue falling year on year; refunds rising inside gross billings; the cost ratio back above 83%. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Yesterday · 14 min

    Lantronix (LTRX): The $12.6M Drone Line That Replaced An $11M Customer

    Lantronix (LTRX) Q4 FY2026 — Fiscal Q4 FY2026 (three months to 30 June): revenue $31.2M, +8.0% YoY and +3.2% QoQ; gross margin 43.7% from 40.0%; operating loss $0.4M from $3.1M. GAAP EPS -$0.01; non-GAAP EPS $0.04 against a $0.03 bar. FULL YEAR: revenue $120.9M, DOWN 1.6% on $122.9M. A brand new unmanned systems line billed $12.6M in fiscal 2026, from what the release calls a minimal contribution the year before. In the same twelve months one customer went from just over $11M of revenue to zero - a sentence that appears only in the 10-K, never in the press release. The two very nearly cancel, which is why group revenue reads -1.6%. Take the new line out and $108.3M against $122.9M is -11.9%. THE CALL: AVOID (3/5, A REAL REPAIR, PAID FOR BY THE OWNERS) — base-case value ~$4.52 vs ~$5.37 today. KEY METRICS: - CALL: AVOID 3/5, fair value $4.52 vs the $5.37 close of 28 August (-15.9%). Bear $3.57, base $5.32, bull $8.35, weighted 35/30/35. Street: 6 analysts, 6 Buys, no Hold or Sell; four targets average $10.00, +86% above the tape and +121% above us - and not one published since the print. - THE SUBSTITUTION: $12.6M of unmanned systems revenue arrived (press release, three times) and just over $11M of one customer left (10-K Item 7, once). Excluding the new line, fiscal 2026 was $108.3M vs $122.9M = -11.9%, against a reported -1.6%. - THE SAME CAUSE TWICE: the 10-K attributes the 171bp gross margin gain primarily to the absence of that customer's lower-margin revenue, not to operating improvement. - THE MIX: Embedded IoT +15.6% to $53.6M, IoT Systems -15.2% to $58.3M, Software & Services +15.5% to $9.0M. Regionally Americas +20.2% while EMEA -30.2% and APJ -31.3% - $16.2M of annual revenue left the rest of the world. - THE BALANCE SHEET WAS BOUGHT: cash $20.1M to $60.5M and debt $11.8M to zero, funded by $44.9M of net share issuance. Shares 39.10M to 46.59M, +19.2%. Strip the raise and cash FALLS $4.5M. About $17M of the ATM remains open. - IN FAIRNESS: free cash flow was a genuine $9.3M (7.7% of revenue) - though $6.3M of it is a share-based pay add-back. Core opex held flat. 30+ unmanned engagements from ~10, NDAA-compliant, partners include Swarmer, DoD Solution and AVT Australia (CACI). - GUIDANCE: Q1 FY2027 revenue $31-33M = +7.4% at the midpoint against the year-ago quarter, NOT double digit. The full-year double-digit promise then needs +10.8% from the three quarters after it, and unmanned to reach $20-27M against $12.6M. - CONSENSUS DEFECT: the vendor's fiscal-2027 average net income of $9.0M over an average EPS of $0.234 solves to 38.4M shares. The company filed 46.7M on its 10-K cover. That $9.0M over the real count is $0.19, not $0.23. What to watch: UP: the September-quarter unmanned number tracking to management's 15-20% of fiscal 2027 revenue (about $5M in Q1); IoT Systems and the international regions stabilising. DOWN: the remaining $17M at-the-market programme being drawn near this price; the memory cost inflation the 10-K flags eating the margin gain; another concentrated customer leaving. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Yesterday · 13 min

    Canadian Solar (CSIQ): The 27 Cents That Sits On No Line Of The Income Statement

    Canadian Solar (CSIQ) Q2 2026 — Q2 2026 (three months to 30 June): net revenues $1,207.7M, -28.7% YoY and +12.0% QoQ, at the high end of the $1.0-1.2BN guide; gross margin 13.9%, inside the 13-15% guide; operating expenses $239.5M against $168.5M of gross profit, so a $71.1M operating loss. Loss attributable $76.9M, -$1.40 a share. Storage shipments 3.7 GWh, +73% YoY, ahead of a 2.8-3.2 GWh guide. On the print (27 Aug) the stock gapped -3.3%, traded to $12.92 and closed +0.79% at $13.98; the NEXT session closed -6.01% at $13.14, a settled two-day reaction of -5.26%. The filed loss per share is -$1.40. The filed loss over the filed share count is -$1.13. The $18.2M in between is a paid-in-kind dividend on Recurrent Energy's redeemable preferred, and it appears on no line of the income statement, no line of the segment table and no line of the cash flow. It reconciles exactly to the filed half-year figure, it grew 45% in a year, and because it is paid in kind it compounds - $73M a year accruing ahead of the common, on an $892M equity. THE CALL: HOLD (2/5, A CHEAP ASSET BASE THAT EARNS NOTHING) — base-case value ~$12.55 vs ~$13.14 today. KEY METRICS: - CALL: HOLD 2/5, fair value $12.55 vs the $13.14 close of 28 August (-4.5%). Bear $5.24, base $13.36, bull $21.48, weighted 30/50/20. Street: 33 analysts, consensus Buy, but ONE live target - Mizuho $18.00 on 15 June, +37% above the tape and +43% above us. - THE LINE ON NO LINE: -$76.9M over 67,907,507 shares is -$1.13. The company filed -$1.40. The $18.2M residual is a paid-in-kind preferred dividend at Recurrent Energy ($12.6M a year ago, $16.1M last quarter). Q1+Q2 residuals reconcile to the filed half-year figure within $0.05M. - THE SPINE: storage shipped 3.7 GWh (+73% YoY) and billed $425.9M against $432.4M a year ago - about $115/kWh from about $202/kWh, -43% per unit. Modules did the opposite: 3.1 GW (-60%) at about $0.19/W from $0.13, +44% per unit. - THE STACK: $892M of equity against $7.1BN of debt - 11.2% of the enterprise. Book value $40.57 a share, so the tape pays 0.32x. Interest took 38% of gross profit against 9% a year ago. Q3 guide $1.3-1.5BN at 13.5-15.5% implies an operating loss at EVERY point; break-even needs a 20.2% gross margin. What to watch: UP: storage revenue per GWh printing back above ~$130/kWh; the deferred Recurrent project sales closing in H2; gross margin recovering toward the 25.1% of one quarter ago. DOWN: another quarter at ~14% gross margin; the preferred accrual growing again off a larger base; total debt drawn past $7.1BN. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Friday · 14 min

    Hafnia (HAFN): A Record Quarter, And A Forward Book Already 30% Lower

    Hafnia Limited (HAFN) Q2 2026 — Q2 2026 (quarter ended 30 June 2026): net profit $277.8M, EPS $0.56 against a $0.544 bar, up from $0.15 a year ago. TCE income $372.9M from $231.2M; adjusted EBITDA $287.3M from $134.2M. Fleet TCE $44,093/day. Dividend $0.5003 a share, a 90% payout. HAFN closed at $8.47, up 2.17% on the BMO print. Hafnia's Q2 2026 was its best quarter since 2022 - $277.8M of net profit, $0.56 a share, and a 90% payout worth $0.5003 that the CEO letter describes as an annualised yield of roughly 21%. Nine pages later, in the same filing, the coverage table says 80% of Q3 earning days are ALREADY CONTRACTED at $30,716 a day against the $44,093 that produced the record - minus 30.3%, in signed contracts rather than a forecast. And 17% of 2027 is fixed at $25,742, all of it time-charter-out, below the $26,041 and $27,347 this fleet earned in Q3 and Q4 2025 before the Gulf conflict began. THE CALL: HOLD (3/5, THE RECORD IS REAL, THE FORWARD BOOK IS 30% LOWER) — base-case value ~$7.95 vs ~$8.47 today. KEY METRICS: - CALL: HOLD 3/5, fair value ~$7.95 vs the $8.47 close (-5.9%). Bear $6.51, base $7.65, bull $10.05. Street: Buy, $8.78 average (Danske NOK 91, Clarksons NOK 90, DNB Carnegie NOK 81, all May 2026, converted at 9.95) - we are 9% below. - THE QUARTER: EPS $0.56 vs $0.544 bar. Net profit $277.8M incl. $39.3M vessel-sale gains and $9.9M TORM dividend income; core vessel earnings ~$228.6M ($0.46/sh). RoE 44.6% annualised. Net LTV 13.0% from 20.2%. - THE FORWARD BOOK: Q3 80% fixed at $30,716/day (-30.3%); H2 53% at $28,917; 2027 17% at $25,742, all time-charter. NAV $8.89/sh, so HAFN trades at 0.95x a peak NAV. Break-even $16,055/day. What to watch: UP: a November coverage table that fixes Q4 2026 and 2027 above $30,000 a day; unfixed Q3/Q4 days beating the book while LR1 pool earnings run near $74,446. DOWN: a 2027 book that extends at or below $25,742; a Q3 dividend near $0.23 as the 90% payout applies to a halved profit; a durable Hormuz reopening. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Friday · 14 min

    IREN Limited (IREN): The $11.4bn Lease Hiding Inside The AI Cloud Story

    IREN Limited (IREN) Q4 FY2026 — FY2026 (year ended 30 June 2026): revenue $707.0M, up 41.1%; AI Cloud revenue $16.4M to $128.8M; Adjusted EBITDA $269.7M to $245.7M, DOWN 8.9%; net loss $702.6M against $86.9M last year; diluted loss per share $2.22 on 316.1M shares. Reported after the close on 27 August; the stock fell 12.5% on 28 August, $40.53 to $35.45, on 88.7M shares, 2.1x the 60-day median. Everyone is arguing about the headline loss per share. What actually matters is Note 4 of the 10-K, which the press release never mentions. IREN has $16.6bn of contracted revenue. Only $5.1bn is services backlog under ASC 606. The other $11.4bn - 69% of the book - is the contracted value of LEASE arrangements under ASC 842, and the 10-K states that no lease revenue was recognised in any period presented. IREN's flagship contract is, in accounting terms, an equipment lease. The market is paying a cloud multiple for it. THE CALL: HOLD (3/5, THE DEMAND IS REAL, THE MULTIPLE IS NOT) — base-case value ~$30.0 vs ~$35.45 today. KEY METRICS: - CALL: HOLD 3/5, fair value ~$30.00 against the $35.45 reaction close, about 15% below. Bear $18.43, base $29.61, bull $42.47, probability-weighted 25/50/25 to $30.03. We accept the Street's own FY2028 revenue of $6.31bn; the disagreement is the margin the book earns and the multiple a two-thirds-leased book deserves. Street: Buy, 17-analyst consensus target $78.19. - THE OPERATING LEVERAGE WENT BACKWARDS: revenue rose $206M in FY2026 while Adjusted EBITDA FELL $24M, an incremental margin of MINUS 11.7%. Margin 53.8% to 34.8% for the year, and 41.1% to 14.0% in the June quarter. SG&A tripled, $136.5M to $449.1M. Stock-based compensation of $205.0M is 83% of the entire $245.7M of Adjusted EBITDA and is added back to reach it. - THE CAPEX DENOMINATOR: every reassurance is scoped to GPU capex only. Footnote 3 defines the roughly two-year payback as GPU capital expenditure divided by contracted revenue less direct costs. But the FY2026 cash flow shows $2,998.0M of property, plant and equipment NET of computer hardware against $1,335.1M of computer hardware - $2.25 of site for every $1.00 of compute. The financings fund the smaller half. What to watch: UP: the first quarter that recognises real lease revenue at a margin near the 86.9% AI Cloud gross line. Horizon 1 was delivered to and accepted by Microsoft in August 2026, so fiscal Q1 2027 is the first clean read on what a delivered hall actually earns. DOWN: another quarter of Adjusted EBITDA margin near the 14.0% posted in the June quarter, or more equity sold ahead of signed contracts. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Friday · 12 min

    Titan Machinery (TITN): The Destock Worked, And The Loss Still Got Wider

    Titan Machinery (TITN) Q2 FY2027 — Q2 FY2027 (quarter ended 31 July 2026): revenue $496.4M, down 9.2%, ahead of a $483.8M consensus; diluted loss per share $0.40 against a three-analyst bar of $0.36. Gross margin 18.6%, up 148bps. Adjusted EBITDA $4.6M from $5.6M. Inventory down 18.3% year on year to $931.5M; floorplan payable down 26.8% to $623.6M; floorplan interest halved to $3.7M. FY2027 profitability guidance reaffirmed at an adjusted loss of $1.25-$1.75. The stock fell 2.07% to $18.42. Titan spent two years promising to clear excess machines off its lots, and it delivered: inventory fell 18.3% year on year against a 9.2% revenue decline, floorplan debt fell 26.8% and floorplan interest was cut in half. The pre-tax loss got wider anyway, $9.2M against $8.2M. The reason is dealer absorption - recurring parts, service and rental gross profit as a share of operating expenses - which fell 578bps to 68.5%, a four-year low, in the very quarter equipment margin recovered. THE CALL: HOLD (3/5, THE BALANCE SHEET HEALED, THE INCOME STATEMENT DID NOT) — base-case value ~$17.0 vs ~$18.42 today. KEY METRICS: - CALL: HOLD 3/5, fair value ~$17.00 vs the $18.42 reaction close (-7.7%). Bear $9.12, base $17.77, bull $23.78. Street: Buy, $23.00 consensus (Northland $25, Baird $17) - but no analyst has published since 15 June 2026. - THE DESTOCK IS REAL: inventory $1.14bn to $931.5M (-18.3%) against revenue -9.2%, so stock cleared roughly twice as fast as sales fell. Floorplan payable $852.2M to $623.6M. Floorplan interest $6.8M to $3.7M. Equipment gross margin 6.61% to 8.52%, up 192bps. - ABSORPTION IS THE PROBLEM: recurring gross profit $68.8M to $64.4M (-6.4%) while operating expense rose 1.5% on 9.2% less revenue. Absorption 76.7% / 72.9% / 74.2% / 68.5% across four fiscal Q2s. One point is worth ~$3.8M pre-tax, ~12c of EPS. What to watch: UP: recurring gross profit growing year on year with operating expense flat, in both the October and January quarters - roughly $0.70 a share of earnings power; a fiscal Q3 that clears last year's $0.05; equipment margin holding above 11.3%. DOWN: a third consecutive year of operating expense rising in dollars on falling revenue; Europe deteriorating past the new down 30-40% outlook; absorption printing below 68%. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Friday · 13 min

    Malibu Boats (MBUU): Revenue +43%, And The Filing That Landed 21 Hours Later

    Malibu Boats (MBUU) Q4 FY2026 — Q4 FY2026 (quarter ended 30 June 2026): net sales $295.5M, up 42.7%; adjusted EPS $0.92 vs a $0.779 consensus; adjusted EBITDA $33.9M, up 72.7%. GAAP diluted EPS was $0.37. Full-year net sales $914.6M, up 13.3%, but FY26 gross margin fell 180bps to 16.0%, adjusted EBITDA fell 1.1% and GAAP EPS fell to $0.09 from $0.76. FY2027 guidance: net sales $1.08-1.12bn, adjusted EBITDA $101-109M. The stock rose 8.11% to $28.80. Malibu bought Finnish builder Saxdor on 2 March 2026, so fiscal 2026 contains four months of it, not twelve. Measured against reported net sales of $914.6M, FY27 guidance looks like 18-22% growth. At 7:45am the NEXT morning Malibu filed an item 8.01 pro forma showing FY2026 net sales of $1,050.9M with Saxdor owned all year - against which the same guide is 2.8-6.6%, and the pro forma bottom line is a LOSS of $0.11 a share. THE CALL: HOLD (3/5, A GOOD QUARTER, EXTRAPOLATED TOO FAR) — base-case value ~$27.0 vs ~$28.8 today. KEY METRICS: - CALL: HOLD 3/5, fair value ~$27.00 vs the $28.80 reaction close (-6%). Bear $22.16, base $27.85, bull $30.70 at 7.0x EV/EBITDA. Street: Hold, consensus target $32.00 (Truist $34, B. Riley $30). - THE BEAT WAS REAL: Q4 adjusted EPS $0.92 vs $0.779, on adjusted basis (the four FY26 quarters sum to $1.61 vs a filed full-year adjusted $1.52; full-year GAAP was $0.09). But $61.2M of the $88.5M revenue increase and 180 of the 235 extra units were Saxdor. - THE FULL YEAR WENT BACKWARDS: legacy unit volume -4.1%, gross margin 17.8% to 16.0%, adjusted EBITDA -1.1%, GAAP net income -88.8%. Net debt $90.6M from net cash. FY26 revenue beat the company's own May guide by ~$29M and produced ~$1M of extra EBITDA. What to watch: UP: two consecutive quarters of gross margin at or above 17.5% with legacy unit volume no longer falling; Saxdor production starting on schedule at Fort Pierce, Florida. DOWN: a second write-down of the Saxdor earnout, already marked from $32.6M to $29.9M; gross margin stalling near 16%; dealer inventories falling faster than guided. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Friday · 14 min

    Harmony Gold (HMY): A Record Gold Year, And The Stock Still Fell 6%

    Harmony Gold (HMY) FY2026 — FY2026 (twelve months ended 30 June 2026): revenue R99,238M (US$5,876M), up 34%. Headline EPS 4,363 SA cents (258 US cents), up 87%. Basic EPS 4,701 SA cents, up 103% - the gap is a R2,779M non-cash impairment reversal. Record adjusted free cash flow US$1,015M. Gold produced 1,429,551oz, DOWN 3%, at an AISC of US$2,195/oz, UP 22% in dollars. First copper: 18,207t from CSA. Net debt R852M, from net CASH of R11,148M, after the US$1.0bn MAC Copper deal. Final dividend 750 SA cents vs 155. FY27 guides 1.30-1.40Moz - below FY26 actual - on roughly US$1.70bn of capex. The 6-K was accepted 27 August pre-open; the ADR closed -6.24% at $21.03 on 7,885,729 shares, then $20.04 on 28 August. Harmony reported the best year in its history and the ADR fell 6.24% on 2.9x median volume, with gold at a record. Here is what the tape worked out. FIRST: the earnings were already public. JSE rules forced a trading statement on 21 August, six days early, and the ADR rose 6.9% that day; the actual print landed INSIDE the pre-announced range. SECOND: revenue is stated AFTER a realised gold hedge loss of R9,649M (US$571M), more than double last year and MORE than the entire record dividend of US$503M. THIRD: 618,000oz of FY27 output is already collared at an average ceiling of R2,403,903/kg, and spot rand gold sits just 2.6% below it. FOURTH: FY27 asks for LESS gold at a HIGHER cost, on roughly US$1.70bn of capex against US$934M of actual FY26 free cash flow, with the net cash already spent. THE CALL: HOLD (3/5, A RECORD YEAR THAT WAS PUBLISHED TWICE, HEDGED HEAVILY, AND ALREADY SPENT) — base-case value ~$18.6 vs ~$20.04 today. KEY METRICS: - CALL: HOLD 3/5, fair value ~$18.60 vs the $20.04 Aug 28 close (-7%). Bear $10.61, base $19.74, bull $24.96. Street: Hold, 10 analysts, avg target $20.97. - HEPS 258 US cents, +87%. Revenue US$5,876M, +34%. But revenue is NET of a US$571M realised gold hedge loss - more than the US$503M record dividend. - FY27 guides LESS gold (1.30-1.40Moz vs 1,429,551) at HIGHER cost, on ~US$1.70bn capex vs US$934M FY26 free cash. 7.8x HEPS, 5.0x EBITDA, 3.9% yield. What to watch: UP: the December half-year showing collared ounces below 400,000, or ceilings rolled up toward the R2,805,213 struck in Q4; gold sustained above $4,750; the rand weakening toward R17.50, which cuts dollar AISC; Eva Copper's environmental approval landing on schedule. DOWN: gold below $4,250, which takes FY27 free cash flow to about US$605M against US$1.70bn of committed capital; the rand through R16.00, inflating dollar costs; grade slipping below the guided 5.60g/t after three years of decline; a further Eva permitting delay; any additional restatement after FY25 was restated. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Friday · 13 min

    PAHC Stock Q4 FY2026: A Record Year, And 3.9% Of It Became Cash

    Phibro Animal Health (PAHC) Q4 FY2026 — FY2026 (year ended June 30, 2026): net sales $1,518.1m vs $1,296.2m, up 17.1%; adjusted EBITDA $255.0m vs $183.7m, up 38.8%; adjusted diluted EPS $3.22 vs $2.17; GAAP diluted EPS $2.43. Q4 adjusted EPS $0.85 against a $0.71 bar, a 19% beat, on sales of $396.7m. Free cash flow $9.9m. The stock opened +9.1% at $39.39 on August 27, traded to $35.01 and closed $36.35, up 0.72% on 432,907 shares, 2.4x its 30-session median. Phibro filed its 10-K at 16:14 Eastern on August 26 and the results 8-K at 16:30, both just after the close, and the stock opened up 9.1% the next morning before closing up 0.72%. Nearly the whole gap was given back in one session. The record is real: net sales $1,518.1m, adjusted EBITDA $255.0m up 38.8%, adjusted EPS $3.22 against a $0.71 fourth-quarter bar it beat by 19%, and FY2027 guidance that came in 5.4% ABOVE the published consensus rather than below it. But $146.1m of the $221.9m sales increase is the company's own disclosed incremental revenue from the Zoetis MFA portfolio, which closed October 31, 2024 - four extra months on a calendar. And $255.0m of adjusted EBITDA produced $9.9m of free cash flow. THE CALL: HOLD (3/5, A REAL BEAT AND A REAL RECORD YEAR THAT CONVERTED ALMOST NONE OF ITSELF INTO CASH) — base-case value ~$37.03 vs ~$36.35 today. KEY METRICS: - THE SPINE: $255.0m of adjusted EBITDA produced $9.9m of free cash flow - 3.9% conversion, against 22.8% the year before. - SAME TWELVE MONTHS: adjusted EBITDA rose $71.3m while operating cash flow FELL $11.2m, from $80.1m to $69.0m. - WHERE IT WENT: working capital absorbed $95.1m, $86.3m of it inventory. Capex rose 54% to $59.1m against $51.5m of D&A. - THE GROWTH: $146.1m of the $221.9m sales increase is disclosed incremental Zoetis MFA revenue - four extra months of a deal that closed Oct 31, 2024. - ONCE LAPPED: in Q4, with both years carrying a full acquisition, MFAs grew $1.1m on $206.5m. Mineral Nutrition was 71% of the quarterly increase. - THE CONCESSION: the beat is real on the proven adjusted basis, guidance came in 5.4% above consensus, and Animal Health margin expanded 303bp. - THE GUIDE: FY2027 adjusted EBITDA +3.1%, but adjusted EPS +8.7% - and 58% of that earnings growth is the tax rate going 23.7% to about 20%. - OUR CALL: HOLD, 3/5, fair value $37.03 vs $36.35. Bear $27.81, base $38.90, bull $48.19. Street average $45.00 across five analysts. What to watch: UP: the Q4 beat is real on the proven basis - $0.85 against $0.713, with sales 4.1% ahead; FY2027 adjusted EPS guidance of $3.41-$3.59 is 5.4% above the $3.32 consensus; Animal Health adjusted EBITDA margin expanded 303bp to 26.1%; Brazil virginiamycin, about $27m of FY2026 sales, is already assumed at near zero in guidance, so registration is unbooked upside; Phibro Forward closed June 30 and management traces nearly one in five guided EBITDA dollars to it; gross leverage 2.9x and no large maturity until $406.6m in FY2030. DOWN: free cash flow $9.9m against $255.0m of adjusted EBITDA, a 3.9% conversion versus 22.8%; operating cash flow FELL $11.2m to $69.0m while adjusted EBITDA rose $71.3m; working capital took $95.1m, of which inventory was $86.3m; inventory $534.9m is 194 days of COGS against 181; capex +54% to $59.1m; the dividend cost $19.5m, twice free cash flow; guidance is +3.1% EBITDA growth and assumes zero FX losses after $12.6m. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Friday · 14 min

    BBW Stock: Build-A-Bear Workshop Q2 FY2026 Earnings - Down 27% As The Growth Leg Was Cut

    Build-A-Bear Workshop, Inc. (BBW) Q2 FY2026 — Q2 FY2026 (thirteen weeks ended August 1, 2026): revenue $115.291m vs $124.247m, -7.2%; e-commerce demand -15.6%; gross margin 54.2% vs 57.6%; pre-tax income $11.631m vs $15.318m; diluted EPS $0.70 vs $0.94 against a $0.645 bar, so it BEAT. The shares gapped -14.99% and closed $28.44, -27.26%, on 14.8x the twelve-month median volume. Build-A-Bear Workshop BEAT its earnings bar - $0.70 against $0.645 - and fell 27.26%, its worst session in a year. What was repriced was not the quarter, it was the plan: in May commercial (wholesale) revenue was guided to grow at least 20% this year, and on August 27 it was guided flat, the Chief Growth Officer was terminated in the same 8-K, and the full-year outlook was cut for the second time in three months. THE CALL: HOLD (3/5, A DEBT-FREE BRAND ON EIGHT TIMES ITS OWN GUIDANCE, WITH ITS GROWTH LEG GUIDED TO ZERO) — base-case value ~$32.30 vs ~$28.44 today. KEY METRICS: - THE STREET AND THE CALL: NOT ONE sell-side target was struck after this print. Two could be sourced AND dated - D.A. Davidson Buy $60 (May 29, 2026) and Northland Outperform $80 (Aug 29, 2025). We value BBW at $32.30 vs $28.44 on three methods spanning 1.08x: DCF $30.76, owner earnings $32.95, EV/EBITDA $33.21. HOLD, 3/5. Bull $44.78, bear $21.71. - THE SPINE: revenue fell $8.956m and cost of merchandise sold ROSE $0.066m, because store occupancy is reported INSIDE that line. Gross profit fell $9.022m - 100.7% of the entire sales decline landed in profit. Gross margin 57.6% to 54.2%, while SG&A actually LEVERAGED 80bp. - THE GROWTH LEG INVERTED IN ONE QUARTER: commercial (wholesale) revenue was +43.6% in Q1 ($7.622m to $10.948m) and -6.3% in Q2 ($8.629m to $8.086m). The CEO: 'certain wholesale opportunities may take longer to realize than previously anticipated.' - SO THE GUIDE REMOVED IT: 'commercial revenue growth of AT LEAST 20%' in May became 'approximately flat' in August - $7.75m out of the plan on last year's $38.750m, and an implied second half 12.4% BELOW last year's. - AND THE CHIEF GROWTH OFFICER WENT WITH IT, IN THE SAME 8-K. Item 5.02: David Henderson terminated WITHOUT CAUSE on August 26, the day before the print. The role was created June 11, 2026 - 76 days earlier - at the CEO handover. Severance $501,500. We label the link an inference, not a proof. - THE YEAR HAS BEEN CUT TWICE IN THREE MONTHS: revenue mid-single-digit GROWTH in March, $530m-$550m in May, $500m-$525m now; adjusted pre-tax $65m-$71m became $53m-$61m. The TOP of the new revenue range, $525m, sits BELOW fiscal 2025's $529.832m: the five-year record streak ends. - READ THE 'BACK-HALF WEIGHTED' YEAR AS ARITHMETIC: H1 adjusted pre-tax was $28.5m, so the guide implies $24.5m-$32.5m for H2 against $32.3m last year. The TOP of the range merely MATCHES last year - and still contains about $6m of IEEPA tariff refund. What to watch: UP: it beat the bar; no borrowings; 8.2x its own adjusted guidance and a 3.23% dividend; 44% of the 674-location fleet is partner-operated or franchised. DOWN: revenue -7.2% while cost of merchandise sold ROSE, so 100.7% of the sales decline landed in profit; the revenue guide now tops out BELOW fiscal 2025's record; cash -64% to $14.0m. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Friday · 14 min

    STDN Stock Q2 2026: TRISO Finally Has A Price, And It Is Not Enough

    Standard Nuclear (STDN) Q2 2026 — Q2 2026 (three months ended June 30, 2026): total revenue $4.74m vs $0.55m, up 756%; product revenue $3.10m from the first commercial TRISO delivery; gross profit $3.18m, a 67.2% margin and the first ever; G&A $5.52m, R&D $1.96m; operating loss $4.30m; net loss $3.42m, $(0.12) per share on 28.0m pre-IPO shares. The stock closed $14.31 on August 27, up 4.45% on 796,970 shares. Standard Nuclear filed its results in an Item 2.02 8-K at 20:26 Eastern on August 26 - an exhibit EDGAR's own index does not list - with the 10-Q following at 08:09 the next morning. The stock opened just 1.0% higher, traded below its prior close, and finished at $14.31, its high of the day and its best close since the July 16 listing. The quarter is the first with a product in it: 50 kgU of TRISO delivered to Radiant for $3.10m, the first complete reactor core of commercially produced TRISO from an independent US maker. It is also the first time this backlog has a price per kilogram behind it. THE CALL: BEARISH (3/5, A REAL FIRST DELIVERY AND A PRICE THAT ALREADY NEEDS MORE PLANTS THAN HAVE BEEN ANNOUNCED) — base-case value ~$8.64 vs ~$14.31 today. KEY METRICS: - THE SPINE: the first delivery prices TRISO. 50 kgU for $3.10m is $62,000/kgU - the first observable price this company has printed. - CROSS-CHECK: the Antares firm one-ton commitment lifted Funded Backlog 93% to $119.3m. That $57.4m for one MTU is $57,400/kgU. - THIRD ROUTE: the seven-ton option added $287.0m to Purchase Options, or $41,000/kgU. Three routes, spanning just 1.51x. - THE CEILING: every announced plant fully ramped is 6.83 MTU a year, or $392m of revenue. The enterprise value is $2.00bn - 5.1x that. - THE REVERSE TEST: at 12% over 5 years to a 20x terminal on a 25% margin, $2.00bn needs $705m of revenue - 12.3 MTU, 1.8x the whole plan. - THE CAVEAT: only 21% of the $576.9m backlog binds. The release itself says it is not a measure of contracted revenue. - THE CONCESSION: first ever gross profit $3.18m at 67.2%, backlog up six-fold since March, $239.9m of cash and no debt at all. - OUR CALL: BEARISH, 3/5, fair value $8.64 vs $14.31. Bear $2.38, base $8.16, bull $15.88. Six targets, all dated August 10, average $15.50. What to watch: UP: revenue $4.74m from $0.55m; first gross profit $3.18m at 67.2%; Total Contract Backlog $91.3m to $576.9m since March; Funded Backlog $8.2m to $119.3m; $239.9m pro forma cash, no debt, total liabilities $9.5m; construction substantially complete at both new plants; DOE approved the preliminary safety analysis for each. DOWN: the six-month column still shows a $1.23m gross LOSS; only 21% of the headline backlog binds and 77% is unexercised options; free cash outflow $28.4m in six months; neither new plant is authorised to operate; two customers were 89% of the quarter; the stock has never closed above its $15.00 IPO price. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Thursday · 13 min

    MESO Stock FY2026: Revenue Up 599%, And 46% Of The Price Is Unapproved

    Mesoblast (MESO) FY2026 — FY2026 (twelve months ended June 30, 2026): total revenue $120.25m vs $17.2m, up 599.2%; net Ryoncil product sales $115.2m vs $11.3m; gross profit ex-amortisation $109.7m, a 91.2% margin; R&D $97.5m vs $34.8m; SG&A $57.3m vs $39.3m; reported loss $57.5m vs $102.1m; loss per ADS $0.444. The ADS closed $18.18 on August 27, up 7.96% on 541,633 shares, 3.0x its 30-session median. Mesoblast filed its audited 20-F at 06:08 Eastern on August 27 and the results 6-K at 07:09, both before the open, and the stock closed up 7.96% on three times median volume. The launch is real: Ryoncil, the first FDA-approved mesenchymal stromal cell therapy, did $115.2m of net product sales in its first full year, the second half out-earned the first by 34.2%, and the fourth quarter alone did $36m. The release leads with a loss cut 44% to $57.5m. But $32.8m of that $44.6m improvement - 73.4% - is the swing in two non-cash fair value lines. Strip them and $103.1m of new revenue bought $11.9m of loss reduction. THE CALL: BEARISH (3/5, A GENUINELY GOOD FIRST LAUNCH YEAR THAT IS NOT WHAT THE SHARE PRICE IS PAYING FOR) — base-case value ~$14.28 vs ~$18.18 today. KEY METRICS: - THE SPINE: the reported loss narrowed $44.6m, but $32.8m of that - 73.4% - is two non-cash fair value marks, not the business. - EX-MARKS: the underlying loss went $82.3m to $70.4m. So $103.1m of new revenue bought $11.9m of improvement - 11.5% drop-through. - THE MARKS: contingent consideration swung from a $14.9m charge to a $12.1m gain; the warrant liability from a $5.0m charge to a gain. - THE CASH: $88.4m received against $120.25m booked. Receivables $14.9m to $57.7m, 175 days, and one customer is the entire product book. - THE BALANCE SHEET: intangibles $566.4m are 99.6% of $568.4m net assets. Borrowings $119.2m vs $102.9m cash - net debt, in year one. - THE CONCESSION: second-half revenue $68.9m vs $51.3m, +34.2%. Q4 product sales $36m annualise to $144m. 50 centres, 280m covered lives. - WHAT YOU PAY FOR: our approved franchise is $9.87 an ADS. The tape is $18.18, so $8.31 - 46% - is six unapproved programmes. - OUR CALL: BEARISH, 3/5, fair value $14.28 vs $18.18. Bear $7.28, base $14.16, bull $21.51. Two April targets, both $35.00. What to watch: UP: revenue $120.25m beat the $117.5m seven-analyst consensus by 2.3%; second-half revenue $68.9m against a $51.3m first half; Q4 product sales $36m annualise to $144m; operating cash outflow only $13.4m in the second half; gross-to-net 13.4% against 14.6%; 50+ transplant centres including 14 of the 15 largest; 280m covered lives; time to treatment 29 days to 8. DOWN: cash receipts $88.4m against $120.25m of revenue; receivables $14.9m to $57.7m, 175 days, and the 20-F says one single external customer is the whole product book; intangibles $566.4m are 99.6% of net assets; borrowings $119.2m against $102.9m of cash is net debt; finance costs $23.8m are 19.8% of revenue. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Thursday · 13 min

    HDL Stock Q2 2026: A 10% Headline On Falling Same-Store Sales

    Super Hi (HDL) Q2 2026 — Q2 2026 (three months ended June 30, 2026): revenue $218.8m vs $198.9m, up 10.0%; Haidilao restaurant revenue $197.8m, up 4.6%; same-store sales $179.4m vs $180.9m, down 0.8%; income from operation $8.1m vs $3.7m, margin 3.7% vs 1.9%; loss for the period $1.9m against a $16.4m profit. The 9658 ordinary line fell 6.93% on August 27 on 1,745,400 shares; the ADS closed $13.275, down 6.05% on 1,157 shares. Super Hi International, which operates the Haidilao hot pot restaurants outside China, reported Q2 2026 at 07:00 Eastern on August 26: revenue $218.8m, up 10.0%, and an operating measure the company defines itself that more than doubled to $8.1m. Five pages later the same release prints the same-store table. Across the 111 restaurants open through both quarters, sales fell 0.8% - $179.4m against $180.9m - after rising 1.7% across the full half. The comparison rolled over inside the half. THE CALL: BEARISH (3/5, A REAL MARGIN GAIN ON A DEMAND LINE THAT TURNED NEGATIVE INSIDE THE HALF) — base-case value ~$10.88 vs ~$13.275 today. KEY METRICS: - THE SPINE: revenue +10.0%, Haidilao restaurant revenue +4.6%, and same-store sales -0.8%. Each layer is smaller than the one above it. - THE MIX: delivery $7.6m (+105.4%) and condiments $13.4m (+119.7%) added $11.2m of the $19.9m the group added. The restaurants added $8.7m. - NO PRICING: average spend per guest was $24.30 in both quarters. Guest visits rose 5.2% to 8.1m. All of the growth is volume and mix. - NORTH AMERICA: same-store sales -8.5%, table turnover 4.0 to 3.6 turns a day, spend per guest $41.00 from $39.10. Fewer guests, higher ticket. - THE CONCESSION: restaurant level margin 6.4% to 10.7% over the half, +430bp, and income from operation $11.8m to $22.1m, up 86.7%. Real. - THE LOSS: a $20.6m currency swing and $4.7m of tax on $2.8m of pre-tax profit made it a $1.9m loss. There is no hedging policy at all. - THE CASH: $269.9m of cash and no borrowings, but $234.4m of leases take about $56.2m a year out below operating cash flow. - OUR CALL: BEARISH, 3/5, fair value $10.88 vs $13.28. Bear $8.54, base $11.30, bull $15.87. Five Hong Kong analysts average $18.45 an ADS. What to watch: UP: restaurant level operating margin went from 6.4% to 10.7% across the half, a 430 basis point gain, and restaurant level profit rose from $24.8m to $44.4m. Staff cost fell to 34.3% of revenue from 35.3%. There are no bank borrowings and cash plus pledged deposits of $269.9m is 31.3% of the market value. DOWN: same-store sales are negative, North American comps fell 8.5% with table turnover down from 4.0 to 3.6 turns a day, average daily revenue per restaurant fell to $17.4k from $17.6k, and 56.3% of the quarter's growth came from delivery and condiments, which are 9.6% of sales. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Thursday · 13 min

    FORTY Stock Q2 2026: A Record Quarter That Was Mostly The Shekel

    Formula Systems (FORTY) Q2 2026 — Q2 2026 (three months ended June 30, 2026): revenue $782.4m vs $602.7m, up 29.8%; gross margin 20.2% vs 20.4%; operating profit $71.6m, up 41.3%, margin 9.2% vs 8.4%; group continuing profit $51.6m of which 54.9% is minority; attributable $23.3m vs $8.8m; diluted continuing EPS $1.47 vs $0.56. Shares closed August 25 at $117.51, up 1.96% on 608 shares, and $121.36 on August 26. Formula Systems reported Q2 2026 before the open on August 25: revenue $782.4m, up 29.8% to a second-quarter record, and diluted continuing EPS of $1.47 against $0.56. Both comparisons are like-for-like - the 2025 columns were restated under IFRS 5 with Sapiens as discontinued operations. But Formula earns in shekels and reports in dollars, and the average rate went from 3.5719 to 2.9511 across the same three months. At last year's rate this quarter is $646.5m, or +7.3% - close to the +6.3% Matrix reported in its own currency. THE CALL: HOLD (3/5, A REAL RECORD ON A CURRENCY TAILWIND, AND AN ASSET DISCOUNT WITH NO CATALYST) — base-case value ~$128.30 vs ~$121.36 today. KEY METRICS: - THE SPINE: revenue +29.8% reported, but the dollar bought 3.5719 shekels in Q2 2025 and 2.9511 in Q2 2026. At last year's rate: $646.5m, or +7.3%. - THE CROSS-CHECK: Matrix is 91.8% of group revenue and reported +6.3% in shekels. Two routes to the same constant-currency answer. - THE OTHER HALF: attributable profit $8.8m to $23.3m. Formula's slice of group profit went 30.5% to 45.1% - worth $7.6m; growth gave $6.9m. - WHY THE SLICE MOVED: net financial expense halved, $11.1m to $5.6m, on interest earned at the parent where there are no minorities. - THE CONCESSION: operating profit $71.6m up 41.3%, margin 9.2% from 8.4% - up 74bp on cost lines 94bp lower. Currency cancels out of a ratio. - THE ASSET: Matrix closed at NIS 99.92 on 92.54m shares = $3.12bn. The filed 47.68% is $1.49bn against a $1.86bn value for all of Formula. - THE DISCOUNT: net asset value $154.46 vs a $121.36 tape, 21.4% off. The market implies $980.2m for the Matrix stake, 34.1% below its quote. - OUR CALL: HOLD, 3/5, fair value $128.30 vs $121.36. Bear $101.28, bull $149.35. No sell-side board: four vendor endpoints return empty. What to watch: UP: at constant currency the group still grew 7.3% and the operating margin widened 74 basis points, which currency cannot explain because costs are earned in shekels too. Net financial debt to capitalisation is negative 27.08% against a 65% covenant. And Formula's filed 47.68% of Tel Aviv listed Matrix is worth $1.49bn against a $1.86bn market value for the whole company. DOWN: a shekel reversal takes reported dollar revenue down about a fifth with no operational change. Formula keeps only 45.1% of group profit, the holding-company discount has no mechanism to close, and 608 shares moved on results day. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Thursday · 14 min

    STRT Stock Q4 FY2026: Record Year, Entire Gain Booked By December

    Strattec Security Corporation (STRT) Q4 FY2026 — Fiscal Q4 and FY2026 (periods ended June 28, 2026): Q4 sales $151.8m vs $152.0m; Q4 gross margin 15.6% vs 16.7%; Q4 profit from operations $6.2m, down 27.5%; Q4 adjusted EBITDA $12.5m vs $13.0m; Q4 adjusted EPS $2.06, identical to a year earlier, against a $1.36 estimate; Q4 GAAP EPS $0.95 vs $2.01. FY sales $579.4m, up 2.5%; FY adjusted EBITDA $50.5m, up 15.3%. Shares closed August 26 at $72.76, down 7.98% from $79.07 on 274,608 shares, 3.4x the 30-day median. Strattec Security reported fiscal Q4 and full-year 2026 adjusted EPS of $2.06 against a $1.36 estimate - a 51% beat - and the stock fell 7.98% the next session. Two things explain it. First, that $2.06 is EXACTLY what the company earned on the same adjusted basis a year earlier, to the cent, while profit from operations fell 27.5%. Second, the company's own per-quarter reconciliation shows the full-year improvement was entirely a first-half event: profit from operations ran +$5.4m and +$2.7m against the prior year in the September and December quarters, then -$2.0m and -$2.3m in March and June. The first half added $8.1m; the second half gave $4.4m back; the whole year gained $3.7m. THE CALL: HOLD (3/5, A GENUINELY BETTER YEAR WHOSE ENTIRE IMPROVEMENT WAS EARNED IN THE FIRST HALF) — base-case value ~$75.99 vs ~$72.76 today. KEY METRICS: - THE SPINE: profit from operations against the prior-year quarter ran +$5.4m, +$2.7m, then -$2.0m and -$2.3m. First half +$8.1m, second half -$4.4m, full year +$3.7m. - THE EXIT RATE: adjusted EBITDA by fiscal 2026 quarter $15.6m, $12.3m, $10.1m, $12.5m. Margin 10.2% to 8.3%, under the 8.5% of the year-ago quarter. - THE BEAT: adjusted EPS $2.06 vs a $1.36 estimate is +51%. It is also identical to the $2.06 of a year earlier. GAAP EPS was $0.95 vs $2.01. - THE TAX: Q4 effective rate 62.4% vs 21.2%. Pre-tax profit fell only 6% but tax expense rose to $6.0m, and a $2.4m discrete tax item is 53% of the whole GAAP-to-adjusted bridge. - THE YEAR, CONCEDED: sales $579.4m up 2.5%, gross margin 16.5% wider by 149 basis points, adjusted EBITDA $50.5m up 15.3%, adjusted EPS $6.88 vs $5.38. - THE BALANCE SHEET: $108.2m cash, $0.0m borrowings, enterprise value $208.0m = 4.12x. Free cash flow $39.0m = $9.80 a share, a 13.5% yield. - BASIS PROVED: all four filed quarters sum exactly to the filed year on sales, operating profit, adjusted EBITDA and both earnings measures. - OUR CALL: HOLD, 3/5, fair value $75.99 vs $72.76. Bear $63.45, base $77.03, bull $86.46. The only sourced Street target is $89.00, set 107 days before this print. What to watch: UP: fiscal 2026 was genuinely better - sales $579.4m up 2.5%, gross margin 16.5% wider by 149 basis points, adjusted EBITDA $50.5m up 15.3%. ZERO borrowings after repaying $8.0m, and $108.2m of cash - $27.21 a share, 37% of the price - leaving an enterprise value of $208.0m, or 4.12x. Free cash flow $39.0m, $9.80 a share, a 13.5% yield, and clean: working capital added just +$0.5m against +$37.5m last year. The board bought $7.4m of stock at $67.10 and authorised a new $40.0m programme. DOWN: the exit quarter margin of 8.3% is below the 10.2% the year opened with AND the 8.5% of the year-ago quarter; the second half annualises at $45.3m against a $50.5m year; fiscal 2027 was guided with the three largest customers down ~6% and a peso move worth ~100 basis points of gross margin; capital spending ran at 49% of depreciation. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Thursday · 14 min

    TUYA Stock Q2 2026: Profit Up 48%, Cash Flow Down 66%

    Tuya Inc. (TUYA) Q2 2026 — Q2 2026 (three months ended June 30, 2026): revenue $92.9m, up 16.0%; net profit $18.6m, up 48.0%; non-GAAP net profit $18.9m, DOWN 5.8%; EPS $0.03 per ADS on both a GAAP and a non-GAAP basis, in line with a $0.03 bar; gross margin 46.3% vs 48.4%; operating cash flow $6.2m vs $18.2m. Shares closed August 25 at $1.79, up 1.70% from $1.76 on 1,721,865 shares. Tuya Inc. reported net profit of $18.6m for the June quarter, up 48.0% from $12.6m, on revenue of $92.9m, up 16.0%. The stock closed up just 1.70%. The reason is in the company's own non-GAAP reconciliation. Tuya defines non-GAAP profit by adding back share-based compensation - and that expense collapsed 92.0%, from $7.479m to $0.602m, as equity awards granted at 2021 IPO valuations finished amortising. On the company's OWN non-GAAP measure, net profit FELL 5.8%, from $20.1m to $18.9m. The $6.877m fall in stock compensation is 84% of the entire $8.220m rise in operating profit. And of the pre-tax profit that remains, financial income of $10.556m - interest on a $976.1m cash pile - exceeded the $9.308m the whole operating business earned. THE CALL: HOLD (3/5, A HEADLINE PROFIT JUMP THAT WAS AN AMORTISATION SCHEDULE EXPIRING) — base-case value ~$1.94 vs ~$1.79 today. KEY METRICS: - THE SPINE: GAAP net profit rose 48.0% to $18.6m, but the company's OWN non-GAAP net profit FELL 5.8%, $20.1m to $18.9m. Same quarter, same filing. - THE CAUSE: share-based compensation fell 92.0%, $7.479m to $0.602m. That $6.877m fall is 84% of the $8.220m rise in operating profit. - THE PROOF: G&A fell $4.670m in total, but the stock compensation inside it fell $5.265m - so every other administrative cost actually rose. - THE BANK: financial income $10.556m vs operating profit $9.308m - 1.13x. Interest is 56.0% of pre-tax profit, and it fell 13.4% across the half. - THE CASH: operating cash flow $18.2m to $6.2m, down 66.1%. Inventory $30.9m to $63.8m (70 to 124 days); fixed assets $15.7m to $35.0m. - THE COUNTER: revenue +16.0% and accelerating four quarters running. Strip the cash out and the enterprise is $127m - just 4.2x non-GAAP operating profit. - THE BOOK: $976.1m of cash and ZERO borrowings against a $1,103m market value. Net cash is $1.58 of the $1.79 share price - 88% of it. - THE CALL: HOLD 3/5, fair value $1.94 vs $1.79 (+8.4%): cash at a 20% haircut plus 16x after-tax operating profit. Bull $2.62, bear $1.39. The only live Street target is $3.69 (Jefferies, 3 March 2026, set 175 days before this print). What to watch: UP: revenue growth accelerating for a fourth straight quarter, +1.2%, +3.4%, +8.3%, +16.0%; PaaS revenue $67.9m, up 16.9%; non-GAAP operating profit up 11.7% to $9.6m; ZERO interest-bearing borrowings; $976.1m of cash, deposits and treasuries against a ~$1,103m market value, so an enterprise value of only ~$127m, or 4.2x trailing non-GAAP operating profit and 0.37x trailing revenue; premium PaaS customers 285 to 318; a $37.0m dividend paid in April. DOWN: non-GAAP net profit fell 5.8% and non-GAAP net margin went 25.1% to 20.4%; gross margin fell 2.0 points to 46.3% so gross profit grew only 11.1%; operating cash flow fell 66.1% to $6.2m as inventory doubled from $30.9m to $63.8m (70 to 124 days) and fixed assets doubled to $35.0m; interest income fell 13.4% across the half as the pile went $1,017.3m to $976.1m; no buyback and the diluted share count rose 0.97%. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

  • Thursday · 14 min

    SFL Stock Q2 2026: The $3.8B Backlog Shrank, Spot Paid The Bill

    SFL Corporation Ltd. (SFL) Q2 2026 — Q2 2026 (three months ended June 30, 2026): total operating revenues $200.8m vs $174.5m in Q1; net income $33.8m; basic and diluted EPS $0.25 vs a $0.14 consensus bar; adjusted EBITDA $129.9m including $7.8m from associates, up 19.9% on the quarter; 90th consecutive quarterly dividend of $0.22. Shares closed August 26 at $12.03, down 1.55% from $12.22 on 2,339,022 shares. SFL Corporation beat on both lines: EPS $0.25 against a $0.14 bar and revenue $200.8m against $179.7m expected, with adjusted EBITDA up 19.9% sequentially to $129.9m. The stock opened higher, ran to $12.75 intraday, then closed down 1.55% at $12.03. The reason is in the six-month interim report rather than the press release. SFL sells a $3.8bn fixed-rate charter backlog with 6.2 years of weighted term - and contracted TIME CHARTER revenue, the line that backlog actually describes, fell 13.8% year on year, from $312.5m to $269.4m. A $43.1m hole. Total revenue barely moved because VOYAGE CHARTER AND POOL revenue - the spot line, in no backlog, repriced every voyage - went from $9.4m to $46.3m and filled 86% of it. Two Suezmax tankers earning $133,000 a day did that. THE CALL: HOLD (3/5, A REAL BEAT DELIVERED BY THE QUARTER OF THE FLEET THAT IS IN NO BACKLOG) — base-case value ~$10.26 vs ~$12.03 today. KEY METRICS: - THE SPINE: six-month contracted time charter revenue fell 13.8%, $312.5m to $269.4m - a $43.1m hole in the one line the $3.8bn backlog describes. - THE FILL: spot voyage and pool revenue rose 4.9x, $9.4m to $46.3m, covering 86% of that hole. Total six-month revenue moved just -1.1%. - THE RATE: two Suezmax tankers averaged $133,000/day spot TCE; two Kamsarmax bulkers $16,000/day. Tanker charter hire jumped $16m on fewer operating days. - THE RIGS: Energy took $24.3m of revenue to $1.1m of adjusted EBITDA (4.7%) and a $19.3m net loss at 50% utilisation. Shipping: $176.5m to $121.0m (68.6%). - THE BRIDGE: Shipping earned $0.39/sh and Energy handed back $0.14/sh, to the filed $0.25. Basis proved: Q1 $0.20 + Q2 $0.25 = the filed half-year $0.45. - THE BOOK: net debt $2,271m vs a $1,668m market value; EV $3,940m = 8.38x normalised adjusted EBITDA of $470m; book value $7.47/sh, so 1.61x. - THE CALL: HOLD 3/5, fair value $10.26 vs $12.03 (-14.7%). An 8.0x asset multiple gives $10.74 and a dividend discount on $0.88 gives $9.78. Bull $14.17, bear $5.91. What to watch: UP: a genuine beat on both lines; adjusted EBITDA +19.9% sequentially; a 68.6% Shipping segment adjusted EBITDA margin; 65% of the backlog to investment grade counterparties over 6.2 years; the 90th consecutive dividend, covered 1.14x by earnings and 2.97x by operating cash flow; $273m of liquidity after redeeming a $150m bond and tapping $78m more at a 6.8% implied yield. DOWN: contracted time charter revenue -13.8% year on year; the spot line that replaced it is four vessels and a $133k/day rate that does not annualise; the Energy segment turned $24.3m of revenue into $1.1m of adjusted EBITDA and a $19.3m net loss at 50% utilisation; net debt of $2,271m against a market value of $1,668m; the share count rose 4.27% in one quarter; first newbuild delivery is 2028. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Showing 1–20 of 96 episodes